O'DAY DANIEL PATRICK (Chairman & CEO) sold 2.5% of their position (15K shares) of GILEAD SCIENCES, INC. on the open market
Open‑market sale worth $2.23M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/2/2026ACC: 0001638643-26-000031
DirectorOfficer· Chairman & CEO
Since Feb 2019
-15K
Net shares
Net seller
$2.23M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
15K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.60K
Price / share
$147.51
Trade value
$236.01K
% of position
0.3%
9/1/2026
592.13K→590.53K
Common Stock
Direct
Shares
−7.99K
Price / share
$148.36
Trade value
$1.19M
% of position
1.4%
9/1/2026
590.53K→582.54K
Common Stock
Direct
Shares
−5.41K
Price / share
$149.38
Trade value
$807.86K
% of position
0.9%
9/1/2026
582.54K→577.13K
Total
Net shares
−15K
Net value
-$2.23M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | S · Sale | −1.60K | $147.51 | $236.01K | 0.3% | 592.13K | 590.53K |
| Common Stock Direct | 9/1/2026 | S · Sale | −7.99K | $148.36 | $1.19M | 1.4% | 590.53K | 582.54K |
| Common Stock Direct | 9/1/2026 | S · Sale | −5.41K | $149.38 | $807.86K | 0.9% | 582.54K | 577.13K |
| Total | −15K | -$2.23M | ||||||
Derivative Transactions0
No derivative transactions reported